936 results on '"Lee, Yena"'
Search Results
252. Carbon-Fiber Based Microelectrode Array Embedded with a Biodegradable Silk Support for In Vivo Neural Recording
253. Molecular Characteristics of Sequence Variants in GATA4 in Patients with 46,XY Disorders of Sex Development without Cardiac Defects
254. The Effect of Loneliness on Distinct Health Outcomes: A Comprehensive Review and Meta-Analysis
255. New use for old drugs: The protective effect of atypical antipsychotics on hepatocellular carcinoma
256. Letter to the editor: Inadequate evidence to support improved patient outcomes with combinatorial pharmacogenomics
257. Cognitive impairment in major depressive disorder
258. Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression
259. Predicting antidepressant response using early changes in cognition: A systematic review
260. Effects of olanzapine and haloperidol on mTORC1 signaling, dendritic outgrowth, and synaptic proteins in rat primary hippocampal neurons under toxic conditions
261. Brain structural networks and connectomes: the brain–obesity interface and its impact on mental health
262. Liraglutide Activates mTORC1 Signaling and AMPA Receptors in Rat Hippocampal Neurons Under Toxic Conditions
263. Characterizing the gut microbiota in adults with bipolar disorder: a pilot study.
264. The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence.
265. Growth, puberty, and bone health in children and adolescents with inflammatory bowel disease.
266. Development and implementation of guidelines for the management of depression: a systematic review.
267. Clinical and molecular spectra of BRAF-associated RASopathy
268. Efficacy of adjunctive infliximab vs. placebo in the treatment of anhedonia in bipolar I/II depression.
269. What is bipolar disorder? A disease model of dysregulated energy expenditure.
270. The efficacy of mind-body (Baduanjin) exercise on self-reported sleep quality and quality of life in elderly subjects with sleep disturbances: a randomized controlled trial.
271. Parsing metabolic heterogeneity in mood disorders: A hypothesis‐driven cluster analysis of glucose and insulin abnormalities.
272. Characterizing, Assessing, and Treating Cognitive Dysfunction in Major Depressive Disorder
273. Increased Incidence of Obstructive Sleep Apnea in Hospitalized Children After Enterovirus Infection: A Nationwide Population-based Cohort Study
274. Stability, reliability, and validity of the THINC‐it screening tool for cognitive impairment in depression: A psychometric exploration in healthy volunteers
275. Evidence supporting a mechanistic role of sirtuins in mood and metabolic disorders
276. Cognitive dysfunction and metabolic comorbidities in mood disorders: A repurposing opportunity for glucagon-like peptide 1 receptor agonists?
277. Comparative efficacy and acceptability of antidiabetic agents for Alzheimer's disease and mild cognitive impairment: A systematic review and network meta-analysis
278. Effects of Antipsychotic Drugs on the Epigenetic Modification of Brain-Derived Neurotrophic Factor Gene Expression in the Hippocampi of Chronic Restraint Stress Rats
279. Cognitive Impairment Mediates Workplace Impairment in Adults With Type 2 Diabetes Mellitus: Results From the Motivaction Study
280. Association between enterovirus infection and speech and language impairments: A nationwide population-based study
281. Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder
282. Antidepressant medication use and nasopharyngeal cancer risk: a nationwide population-based study
283. The use of brexpiprazole amongst individuals with insufficient outcomes with aripiprazole or bupropion: A case series
284. A computational algorithm for personalized medicine in schizophrenia
285. Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: A systematic review
286. Pharmacological Treatment of Cognitive Symptoms in Major Depressive Disorder
287. Sex differences in the mediators of functional disability in Major Depressive Disorder
288. Risks of road injuries in patients with bipolar disorder and associations with drug treatments: A population-based matched cohort study
289. Correlation between brain circuit segregation and obesity
290. Comparison of dietary behavior and consumption of processed beverage depend on food insecurity status of adolescents in vientiane, Lao PDR
291. Suicide risk reduction in youths with attention-deficit/hyperactivity disorder prescribed methylphenidate: A Taiwan nationwide population-based cohort study
292. Sleep Duration and Quality as Related to Left Ventricular Structure and Function
293. Air pollution, aeroallergens and suicidality: a review of the effects of air pollution and aeroallergens on suicidal behavior and an exploration of possible mechanisms
294. Digital revolution in depression: A technologies update for clinicians
295. Assessment of brain functional connectome alternations and correlation with depression and anxiety in major depressive disorders
296. Treatment with a GLP−1R agonist over four weeks promotes weight loss-moderated changes in frontal-striatal brain structures in individuals with mood disorders
297. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder
298. Factors affecting lumbar surgery outcome: A nation-wide, population-based retrospective study
299. Drug-drug interactions as a result of co-administering Δ9-THC and CBD with other psychotropic agents
300. Association of Tic Disorders and Enterovirus Infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.